Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00830713 · ClinicalTrials.gov registry record · Phase 3
Vitiligo Skin Transplantation
A Phase 3 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
NCT00830713 is a Phase 3 study that has completed, run by Henry Ford Health System. The registered enrollment target is 40 participants.
The verdict
NCT00830713, a Phase 3 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
Study Summary
In vitiligo, the melanocytes are lost from the skin in certain areas. One treatment for vitiligo takes the melanocytes from areas of normal skin and places them on areas of that same person's body which have lost their color. This is called the melanocyte-keratinocyte transplantation procedure (MKTP). This procedure has been used successfully in over 3000 cases in India and Saudi Arabia. The purpose of this study is to see if it is effective when performed at the investigators' institution.
Interventions
- PROCEDURE Melanocyte-keratinocyte transplantation procedure (MKTP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00830713
The ClinicalTrials.gov registry entry for NCT00830713 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Melanocyte-keratinocyte transplantation procedure (MKTP) is the first listed.
NCT00830713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00830713 about?
NCT00830713 is a clinical study titled "Vitiligo Skin Transplantation". In vitiligo, the melanocytes are lost from the skin in certain areas. One treatment for vitiligo takes the melanocytes from areas of normal skin and places them on areas of that same person's body which have lost their color. This is called the melanocyte-keratinocyte transplantation procedure (MKTP...
What is the current status of trial NCT00830713?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2009-01. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00830713?
The interventions under investigation include: Melanocyte-keratinocyte transplantation procedure (MKTP) (PROCEDURE).
Who is sponsoring clinical trial NCT00830713?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.